Global Recombinant Vaccines Market Insights and Forecast to 2028

Report ID: 1802473 | Published Date: Jan 2025 | No. of Page: 90 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Recombinant Vaccines Product Introduction
    1.2 Market by Type
        1.2.1 Global Recombinant Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Subunit Recombinant Vaccines
        1.2.3 Attenuated Recombinant Vaccines
        1.2.4 Vector Recombinant Vaccines
    1.3 Market by Application
        1.3.1 Global Recombinant Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Recombinant Human Vaccines
        1.3.3 Animal Recombinant Vaccines
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Recombinant Vaccines Sales Estimates and Forecasts 2017-2028
    2.2 Global Recombinant Vaccines Revenue Estimates and Forecasts 2017-2028
    2.3 Global Recombinant Vaccines Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Recombinant Vaccines Sales by Region
        2.4.1 Global Recombinant Vaccines Sales by Region (2017-2022)
        2.4.2 Global Sales Recombinant Vaccines by Region (2023-2028)
    2.5 Global Recombinant Vaccines Revenue by Region
        2.5.1 Global Recombinant Vaccines Revenue by Region (2017-2022)
        2.5.2 Global Recombinant Vaccines Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Recombinant Vaccines Sales by Manufacturers
        3.1.1 Global Top Recombinant Vaccines Manufacturers by Sales (2017-2022)
        3.1.2 Global Recombinant Vaccines Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Recombinant Vaccines in 2021
    3.2 Global Recombinant Vaccines Revenue by Manufacturers
        3.2.1 Global Recombinant Vaccines Revenue by Manufacturers (2017-2022)
        3.2.2 Global Recombinant Vaccines Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Recombinant Vaccines Revenue in 2021
    3.3 Global Recombinant Vaccines Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Recombinant Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Recombinant Vaccines Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Recombinant Vaccines Sales by Type
        4.1.1 Global Recombinant Vaccines Historical Sales by Type (2017-2022)
        4.1.2 Global Recombinant Vaccines Forecasted Sales by Type (2023-2028)
        4.1.3 Global Recombinant Vaccines Sales Market Share by Type (2017-2028)
    4.2 Global Recombinant Vaccines Revenue by Type
        4.2.1 Global Recombinant Vaccines Historical Revenue by Type (2017-2022)
        4.2.2 Global Recombinant Vaccines Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Recombinant Vaccines Revenue Market Share by Type (2017-2028)
    4.3 Global Recombinant Vaccines Price by Type
        4.3.1 Global Recombinant Vaccines Price by Type (2017-2022)
        4.3.2 Global Recombinant Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Recombinant Vaccines Sales by Application
        5.1.1 Global Recombinant Vaccines Historical Sales by Application (2017-2022)
        5.1.2 Global Recombinant Vaccines Forecasted Sales by Application (2023-2028)
        5.1.3 Global Recombinant Vaccines Sales Market Share by Application (2017-2028)
    5.2 Global Recombinant Vaccines Revenue by Application
        5.2.1 Global Recombinant Vaccines Historical Revenue by Application (2017-2022)
        5.2.2 Global Recombinant Vaccines Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Recombinant Vaccines Revenue Market Share by Application (2017-2028)
    5.3 Global Recombinant Vaccines Price by Application
        5.3.1 Global Recombinant Vaccines Price by Application (2017-2022)
        5.3.2 Global Recombinant Vaccines Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Recombinant Vaccines Market Size by Type
        6.1.1 North America Recombinant Vaccines Sales by Type (2017-2028)
        6.1.2 North America Recombinant Vaccines Revenue by Type (2017-2028)
    6.2 North America Recombinant Vaccines Market Size by Application
        6.2.1 North America Recombinant Vaccines Sales by Application (2017-2028)
        6.2.2 North America Recombinant Vaccines Revenue by Application (2017-2028)
    6.3 North America Recombinant Vaccines Market Size by Country
        6.3.1 North America Recombinant Vaccines Sales by Country (2017-2028)
        6.3.2 North America Recombinant Vaccines Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Recombinant Vaccines Market Size by Type
        7.1.1 Europe Recombinant Vaccines Sales by Type (2017-2028)
        7.1.2 Europe Recombinant Vaccines Revenue by Type (2017-2028)
    7.2 Europe Recombinant Vaccines Market Size by Application
        7.2.1 Europe Recombinant Vaccines Sales by Application (2017-2028)
        7.2.2 Europe Recombinant Vaccines Revenue by Application (2017-2028)
    7.3 Europe Recombinant Vaccines Market Size by Country
        7.3.1 Europe Recombinant Vaccines Sales by Country (2017-2028)
        7.3.2 Europe Recombinant Vaccines Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Recombinant Vaccines Market Size by Type
        8.1.1 Asia Pacific Recombinant Vaccines Sales by Type (2017-2028)
        8.1.2 Asia Pacific Recombinant Vaccines Revenue by Type (2017-2028)
    8.2 Asia Pacific Recombinant Vaccines Market Size by Application
        8.2.1 Asia Pacific Recombinant Vaccines Sales by Application (2017-2028)
        8.2.2 Asia Pacific Recombinant Vaccines Revenue by Application (2017-2028)
    8.3 Asia Pacific Recombinant Vaccines Market Size by Region
        8.3.1 Asia Pacific Recombinant Vaccines Sales by Region (2017-2028)
        8.3.2 Asia Pacific Recombinant Vaccines Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Recombinant Vaccines Market Size by Type
        9.1.1 Latin America Recombinant Vaccines Sales by Type (2017-2028)
        9.1.2 Latin America Recombinant Vaccines Revenue by Type (2017-2028)
    9.2 Latin America Recombinant Vaccines Market Size by Application
        9.2.1 Latin America Recombinant Vaccines Sales by Application (2017-2028)
        9.2.2 Latin America Recombinant Vaccines Revenue by Application (2017-2028)
    9.3 Latin America Recombinant Vaccines Market Size by Country
        9.3.1 Latin America Recombinant Vaccines Sales by Country (2017-2028)
        9.3.2 Latin America Recombinant Vaccines Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Recombinant Vaccines Market Size by Type
        10.1.1 Middle East and Africa Recombinant Vaccines Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Recombinant Vaccines Revenue by Type (2017-2028)
    10.2 Middle East and Africa Recombinant Vaccines Market Size by Application
        10.2.1 Middle East and Africa Recombinant Vaccines Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Recombinant Vaccines Revenue by Application (2017-2028)
    10.3 Middle East and Africa Recombinant Vaccines Market Size by Country
        10.3.1 Middle East and Africa Recombinant Vaccines Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Recombinant Vaccines Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Merck & Co., Inc
        11.1.1 Merck & Co., Inc Corporation Information
        11.1.2 Merck & Co., Inc Overview
        11.1.3 Merck & Co., Inc Recombinant Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Merck & Co., Inc Recombinant Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Merck & Co., Inc Recent Developments
    11.2 Green Cross Corporation
        11.2.1 Green Cross Corporation Corporation Information
        11.2.2 Green Cross Corporation Overview
        11.2.3 Green Cross Corporation Recombinant Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Green Cross Corporation Recombinant Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Green Cross Corporation Recent Developments
    11.3 Pfizer Inc.
        11.3.1 Pfizer Inc. Corporation Information
        11.3.2 Pfizer Inc. Overview
        11.3.3 Pfizer Inc. Recombinant Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Pfizer Inc. Recombinant Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Pfizer Inc. Recent Developments
    11.4 Bayer AG
        11.4.1 Bayer AG Corporation Information
        11.4.2 Bayer AG Overview
        11.4.3 Bayer AG Recombinant Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Bayer AG Recombinant Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Bayer AG Recent Developments
    11.5 Sanofi S A.
        11.5.1 Sanofi S A. Corporation Information
        11.5.2 Sanofi S A. Overview
        11.5.3 Sanofi S A. Recombinant Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Sanofi S A. Recombinant Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Sanofi S A. Recent Developments
    11.6 Protein Science Corporation
        11.6.1 Protein Science Corporation Corporation Information
        11.6.2 Protein Science Corporation Overview
        11.6.3 Protein Science Corporation Recombinant Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Protein Science Corporation Recombinant Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Protein Science Corporation Recent Developments
    11.7 GlaxoSmithKline Plc.
        11.7.1 GlaxoSmithKline Plc. Corporation Information
        11.7.2 GlaxoSmithKline Plc. Overview
        11.7.3 GlaxoSmithKline Plc. Recombinant Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 GlaxoSmithKline Plc. Recombinant Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 GlaxoSmithKline Plc. Recent Developments
    11.8 Novartis AG
        11.8.1 Novartis AG Corporation Information
        11.8.2 Novartis AG Overview
        11.8.3 Novartis AG Recombinant Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Novartis AG Recombinant Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Novartis AG Recent Developments
    11.9 Bharat Biotech
        11.9.1 Bharat Biotech Corporation Information
        11.9.2 Bharat Biotech Overview
        11.9.3 Bharat Biotech Recombinant Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Bharat Biotech Recombinant Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Bharat Biotech Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Recombinant Vaccines Industry Chain Analysis
    12.2 Recombinant Vaccines Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Recombinant Vaccines Production Mode & Process
    12.4 Recombinant Vaccines Sales and Marketing
        12.4.1 Recombinant Vaccines Sales Channels
        12.4.2 Recombinant Vaccines Distributors
    12.5 Recombinant Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Recombinant Vaccines Industry Trends
    13.2 Recombinant Vaccines Market Drivers
    13.3 Recombinant Vaccines Market Challenges
    13.4 Recombinant Vaccines Market Restraints
14 Key Findings in The Global Recombinant Vaccines Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Recombinant Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Subunit Recombinant Vaccines
    Table 3. Major Manufacturers of Attenuated Recombinant Vaccines
    Table 4. Major Manufacturers of Vector Recombinant Vaccines
    Table 5. Global Recombinant Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Recombinant Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Recombinant Vaccines Sales by Region (2017-2022) & (K Units)
    Table 8. Global Recombinant Vaccines Sales Market Share by Region (2017-2022)
    Table 9. Global Recombinant Vaccines Sales by Region (2023-2028) & (K Units)
    Table 10. Global Recombinant Vaccines Sales Market Share by Region (2023-2028)
    Table 11. Global Recombinant Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Recombinant Vaccines Revenue Market Share by Region (2017-2022)
    Table 13. Global Recombinant Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Recombinant Vaccines Revenue Market Share by Region (2023-2028)
    Table 15. Global Recombinant Vaccines Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global Recombinant Vaccines Sales Share by Manufacturers (2017-2022)
    Table 17. Global Recombinant Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Recombinant Vaccines Revenue Share by Manufacturers (2017-2022)
    Table 19. Recombinant Vaccines Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 20. Global Recombinant Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Recombinant Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Vaccines as of 2021)
    Table 22. Recombinant Vaccines Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Recombinant Vaccines Product Offered
    Table 24. Date of Manufacturers Enter into Recombinant Vaccines Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Recombinant Vaccines Sales by Type (2017-2022) & (K Units)
    Table 27. Global Recombinant Vaccines Sales by Type (2023-2028) & (K Units)
    Table 28. Global Recombinant Vaccines Sales Share by Type (2017-2022)
    Table 29. Global Recombinant Vaccines Sales Share by Type (2023-2028)
    Table 30. Global Recombinant Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Recombinant Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Recombinant Vaccines Revenue Share by Type (2017-2022)
    Table 33. Global Recombinant Vaccines Revenue Share by Type (2023-2028)
    Table 34. Recombinant Vaccines Price by Type (2017-2022) & (USD/Unit)
    Table 35. Global Recombinant Vaccines Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 36. Global Recombinant Vaccines Sales by Application (2017-2022) & (K Units)
    Table 37. Global Recombinant Vaccines Sales by Application (2023-2028) & (K Units)
    Table 38. Global Recombinant Vaccines Sales Share by Application (2017-2022)
    Table 39. Global Recombinant Vaccines Sales Share by Application (2023-2028)
    Table 40. Global Recombinant Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Recombinant Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Recombinant Vaccines Revenue Share by Application (2017-2022)
    Table 43. Global Recombinant Vaccines Revenue Share by Application (2023-2028)
    Table 44. Recombinant Vaccines Price by Application (2017-2022) & (USD/Unit)
    Table 45. Global Recombinant Vaccines Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 46. North America Recombinant Vaccines Sales by Type (2017-2022) & (K Units)
    Table 47. North America Recombinant Vaccines Sales by Type (2023-2028) & (K Units)
    Table 48. North America Recombinant Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Recombinant Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Recombinant Vaccines Sales by Application (2017-2022) & (K Units)
    Table 51. North America Recombinant Vaccines Sales by Application (2023-2028) & (K Units)
    Table 52. North America Recombinant Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Recombinant Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Recombinant Vaccines Sales by Country (2017-2022) & (K Units)
    Table 55. North America Recombinant Vaccines Sales by Country (2023-2028) & (K Units)
    Table 56. North America Recombinant Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Recombinant Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Recombinant Vaccines Sales by Type (2017-2022) & (K Units)
    Table 59. Europe Recombinant Vaccines Sales by Type (2023-2028) & (K Units)
    Table 60. Europe Recombinant Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Recombinant Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Recombinant Vaccines Sales by Application (2017-2022) & (K Units)
    Table 63. Europe Recombinant Vaccines Sales by Application (2023-2028) & (K Units)
    Table 64. Europe Recombinant Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Recombinant Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Recombinant Vaccines Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Recombinant Vaccines Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Recombinant Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Recombinant Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Recombinant Vaccines Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific Recombinant Vaccines Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific Recombinant Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Recombinant Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Recombinant Vaccines Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific Recombinant Vaccines Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific Recombinant Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Recombinant Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Recombinant Vaccines Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific Recombinant Vaccines Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific Recombinant Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Recombinant Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Recombinant Vaccines Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America Recombinant Vaccines Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America Recombinant Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Recombinant Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Recombinant Vaccines Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America Recombinant Vaccines Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America Recombinant Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Recombinant Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Recombinant Vaccines Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America Recombinant Vaccines Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America Recombinant Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Recombinant Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Recombinant Vaccines Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa Recombinant Vaccines Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa Recombinant Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Recombinant Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Recombinant Vaccines Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa Recombinant Vaccines Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa Recombinant Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Recombinant Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Recombinant Vaccines Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa Recombinant Vaccines Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa Recombinant Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Recombinant Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Merck & Co., Inc Corporation Information
    Table 107. Merck & Co., Inc Description and Major Businesses
    Table 108. Merck & Co., Inc Recombinant Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 109. Merck & Co., Inc Recombinant Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Merck & Co., Inc Recent Developments
    Table 111. Green Cross Corporation Corporation Information
    Table 112. Green Cross Corporation Description and Major Businesses
    Table 113. Green Cross Corporation Recombinant Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 114. Green Cross Corporation Recombinant Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Green Cross Corporation Recent Developments
    Table 116. Pfizer Inc. Corporation Information
    Table 117. Pfizer Inc. Description and Major Businesses
    Table 118. Pfizer Inc. Recombinant Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 119. Pfizer Inc. Recombinant Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Pfizer Inc. Recent Developments
    Table 121. Bayer AG Corporation Information
    Table 122. Bayer AG Description and Major Businesses
    Table 123. Bayer AG Recombinant Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 124. Bayer AG Recombinant Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Bayer AG Recent Developments
    Table 126. Sanofi S A. Corporation Information
    Table 127. Sanofi S A. Description and Major Businesses
    Table 128. Sanofi S A. Recombinant Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 129. Sanofi S A. Recombinant Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Sanofi S A. Recent Developments
    Table 131. Protein Science Corporation Corporation Information
    Table 132. Protein Science Corporation Description and Major Businesses
    Table 133. Protein Science Corporation Recombinant Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 134. Protein Science Corporation Recombinant Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Protein Science Corporation Recent Developments
    Table 136. GlaxoSmithKline Plc. Corporation Information
    Table 137. GlaxoSmithKline Plc. Description and Major Businesses
    Table 138. GlaxoSmithKline Plc. Recombinant Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 139. GlaxoSmithKline Plc. Recombinant Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. GlaxoSmithKline Plc. Recent Developments
    Table 141. Novartis AG Corporation Information
    Table 142. Novartis AG Description and Major Businesses
    Table 143. Novartis AG Recombinant Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 144. Novartis AG Recombinant Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Novartis AG Recent Developments
    Table 146. Bharat Biotech Corporation Information
    Table 147. Bharat Biotech Description and Major Businesses
    Table 148. Bharat Biotech Recombinant Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 149. Bharat Biotech Recombinant Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Bharat Biotech Recent Developments
    Table 151. Key Raw Materials Lists
    Table 152. Raw Materials Key Suppliers Lists
    Table 153. Recombinant Vaccines Distributors List
    Table 154. Recombinant Vaccines Customers List
    Table 155. Recombinant Vaccines Market Trends
    Table 156. Recombinant Vaccines Market Drivers
    Table 157. Recombinant Vaccines Market Challenges
    Table 158. Recombinant Vaccines Market Restraints
    Table 159. Research Programs/Design for This Report
    Table 160. Key Data Information from Secondary Sources
    Table 161. Key Data Information from Primary Sources
List of Figures
    Figure 1. Recombinant Vaccines Product Picture
    Figure 3. Global Recombinant Vaccines Market Share by Type in 2021 & 2028
    Figure 3. Subunit Recombinant Vaccines Product Picture
    Figure 4. Attenuated Recombinant Vaccines Product Picture
    Figure 5. Vector Recombinant Vaccines Product Picture
    Figure 6. Global Recombinant Vaccines Market Share by Application in 2021 & 2028
    Figure 7. Recombinant Human Vaccines
    Figure 8. Animal Recombinant Vaccines
    Figure 9. Recombinant Vaccines Report Years Considered
    Figure 10. Global Recombinant Vaccines Sales 2017-2028 (K Units)
    Figure 11. Global Recombinant Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Recombinant Vaccines Revenue 2017-2028 (US$ Million)
    Figure 13. Global Recombinant Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Recombinant Vaccines Sales Market Share by Region (2017-2022)
    Figure 15. Global Recombinant Vaccines Sales Market Share by Region (2023-2028)
    Figure 16. North America Recombinant Vaccines Sales YoY (2017-2028) & (K Units)
    Figure 17. North America Recombinant Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Recombinant Vaccines Sales YoY (2017-2028) & (K Units)
    Figure 19. Europe Recombinant Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Recombinant Vaccines Sales YoY (2017-2028) & (K Units)
    Figure 21. Asia-Pacific Recombinant Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Recombinant Vaccines Sales YoY (2017-2028) & (K Units)
    Figure 23. Latin America Recombinant Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Recombinant Vaccines Sales YoY (2017-2028) & (K Units)
    Figure 25. Middle East & Africa Recombinant Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Recombinant Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Recombinant Vaccines in the World: Market Share by Recombinant Vaccines Revenue in 2021
    Figure 28. Global Recombinant Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Recombinant Vaccines Sales Market Share by Type (2017-2028)
    Figure 30. Global Recombinant Vaccines Revenue Market Share by Type (2017-2028)
    Figure 31. Global Recombinant Vaccines Sales Market Share by Application (2017-2028)
    Figure 32. Global Recombinant Vaccines Revenue Market Share by Application (2017-2028)
    Figure 33. North America Recombinant Vaccines Sales Market Share by Type (2017-2028)
    Figure 34. North America Recombinant Vaccines Revenue Market Share by Type (2017-2028)
    Figure 35. North America Recombinant Vaccines Sales Market Share by Application (2017-2028)
    Figure 36. North America Recombinant Vaccines Revenue Market Share by Application (2017-2028)
    Figure 37. North America Recombinant Vaccines Sales Share by Country (2017-2028)
    Figure 38. North America Recombinant Vaccines Revenue Share by Country (2017-2028)
    Figure 39. U.S. Recombinant Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Recombinant Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Recombinant Vaccines Sales Market Share by Type (2017-2028)
    Figure 42. Europe Recombinant Vaccines Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Recombinant Vaccines Sales Market Share by Application (2017-2028)
    Figure 44. Europe Recombinant Vaccines Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Recombinant Vaccines Sales Share by Country (2017-2028)
    Figure 46. Europe Recombinant Vaccines Revenue Share by Country (2017-2028)
    Figure 47. Germany Recombinant Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 48. France Recombinant Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Recombinant Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Recombinant Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Recombinant Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Recombinant Vaccines Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Recombinant Vaccines Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Recombinant Vaccines Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Recombinant Vaccines Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Recombinant Vaccines Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Recombinant Vaccines Revenue Share by Region (2017-2028)
    Figure 58. China Recombinant Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Recombinant Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Recombinant Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 61. India Recombinant Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Recombinant Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan Recombinant Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Recombinant Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Recombinant Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Recombinant Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines Recombinant Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Recombinant Vaccines Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Recombinant Vaccines Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Recombinant Vaccines Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Recombinant Vaccines Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Recombinant Vaccines Sales Share by Country (2017-2028)
    Figure 73. Latin America Recombinant Vaccines Revenue Share by Country (2017-2028)
    Figure 74. Mexico Recombinant Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Recombinant Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Recombinant Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Recombinant Vaccines Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Recombinant Vaccines Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Recombinant Vaccines Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Recombinant Vaccines Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Recombinant Vaccines Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Recombinant Vaccines Revenue Share by Country (2017-2028)
    Figure 83. Turkey Recombinant Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Recombinant Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 85. U.A.E Recombinant Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 86. Recombinant Vaccines Value Chain
    Figure 87. Recombinant Vaccines Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck & Co., Inc
Green Cross Corporation
Pfizer Inc.
Bayer AG
Sanofi S A.
Protein Science Corporation
GlaxoSmithKline Plc.
Novartis AG
Bharat Biotech
Frequently Asked Questions
Recombinant Vaccines report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Recombinant Vaccines report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Recombinant Vaccines report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Rx Medical Food

Rx Medical Food market is segmented by Type and by Application. Players, stakeholders, and other  ... Read More

Salt Substitutes

Salt Substitutes market is segmented by Type and by Application. Players, stakeholders, and other ... Read More